Literature DB >> 10519416

In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.

R Abramovitch1, H Dafni, E Smouha, L E Benjamin, M Neeman.   

Abstract

One of the hallmarks of tumor neovasculature is the prevalence of immature vessels manifested by the low degree of recruitment of vascular mural cells such as pericytes and smooth muscle cells. This difference in the architecture of the vascular bed provides an important therapeutic window for inflicting tumor-selective vascular damage. Here we demonstrate the application of gradient echo magnetic resonance imaging (MRI) for noninvasive in vivo mapping of vascular maturation, manifested by the ability of mature vessels to dilate in response to elevated levels of CO2. Histological alpha-actin staining showed a match between dilating vessels detected by MRI and vessels coated with smooth muscle cells. Switchable, vascular endothelial growth factor (VEGF)-overexpressing tumors (C6-pTET-VEGF rat glioma s.c. tumors in nude mice) displayed high vascular function and significant vascular damage upon VEGF withdrawal. However, damage was restricted to nondilating vessels, whereas mature dilating tumor vessels were resistant to VEGF withdrawal. Thus, MRI provides in vivo visualization of vascular maturity and prognosis of vascular obliteration induced by VEGF withdrawal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519416

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  Applications of magnetic resonance in model systems: tumor biology and physiology.

Authors:  R J Gillies; Z M Bhujwalla; J Evelhoch; M Garwood; M Neeman; S P Robinson; C H Sotak; B Van Der Sanden
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  Perspectives: MRI of angiogenesis.

Authors:  Michal Neeman
Journal:  J Magn Reson       Date:  2018-04-12       Impact factor: 2.229

Review 3.  Models for assessment of angiogenesis in gliomas.

Authors:  R H Goldbrunner; S Wagner; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 4.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 5.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 6.  Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis.

Authors:  Reut Avni; Batya Cohen; Michal Neeman
Journal:  NMR Biomed       Date:  2011-01-17       Impact factor: 4.044

7.  Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI.

Authors:  Scott D Packard; Joseph B Mandeville; Tomotsugu Ichikawa; Keiro Ikeda; Kinya Terada; Stephanie Niloff; E Antonio Chiocca; Bruce R Rosen; John J A Marota
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

8.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.

Authors:  Barjor Gimi; Arvind P Pathak; Ellen Ackerstaff; Kristine Glunde; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04-01       Impact factor: 10.961

Review 9.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

10.  Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

Authors:  Orit Goldshmidt; Eyal Zcharia; Rinat Abramovitch; Shula Metzger; Helena Aingorn; Yael Friedmann; Volker Schirrmacher; Eduardo Mitrani; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.